Clinical Trials Browser

Flow Cytometry × Head & Neck × Clear all

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Phase 1 Terminated

BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00482872 2017-03-14

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00896948 2017-03-14

Study of Proteins in Head and Neck Cancer Cells

Head and Neck Neoplasms

NCT00897988 2017-03-14

DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00589186 2013-12-18

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

Phase 2 Unknown

Head and Neck Neoplasms

NCT00690872 2009-06-29

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Phase 2 Unknown

Head and Neck Neoplasms